Stay updated on Nivolumab for Peripheral T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Added Extranodal nasal NK/T cell lymphoma and CD4+/CD56+ hematodermic neoplasm to the study's listed conditions.
    Difference
    0.1%
    Check dated 2026-04-02T00:11:08.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 from the page.
    Difference
    0.0%
    Check dated 2026-03-25T20:27:23.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T11:37:34.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and the previous funding/operation-status notice (Revision: v3.4.1) was removed; these are minor site maintenance updates that do not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:36:10.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with operating status details for the NIH/Clinical Center and updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T23:52:19.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Glossary feature is now shown on the page. The revision label updated to v3.4.0 and capitalization of certain labels changed (Last Update Submitted that Met QC Criteria; No FEAR Act Data) replacing the previous lowercase forms and v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T22:07:42.000Z thumbnail image

Stay in the know with updates to Nivolumab for Peripheral T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Peripheral T-cell Lymphoma Clinical Trial page.